Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity

dc.contributor.authorMartinez-Peinado, Nieves
dc.contributor.authorCortés Serra, Núria
dc.contributor.authorTorras Claveria, Laura
dc.contributor.authorPinazo, Maria-Jesus
dc.contributor.authorGascón i Brustenga, Joaquim
dc.contributor.authorBastida Armengol, Jaume
dc.contributor.authorAlonso Padilla, Julio
dc.date.accessioned2021-06-03T08:03:17Z
dc.date.available2021-06-03T08:03:17Z
dc.date.issued2020
dc.date.updated2021-06-03T08:03:17Z
dc.description.abstractBackground: Chagas disease, caused by the protozoan Trypanosoma cruzi, is a neglected disease that afects ~7 million people worldwide. Development of new drugs to treat the infection remains a priority since those currently available have frequent side efects and limited efcacy at the chronic stage. Natural products provide a pool of diver sity structures to lead the chemical synthesis of novel molecules for this purpose. Herein we analyzed the anti-T. cruzi activity of nine alkaloids derived from plants of the family Amaryllidaceae. Methods: The activity of each alkaloid was assessed by means of an anti-T. cruzi phenotypic assay. We further evalu ated the compounds that inhibited parasite growth on two distinct cytotoxicity assays to discard those that were toxic to host cells and assure parasite selectivity. Results: We identifed a single compound (hippeastrine) that was selectively active against the parasite yielding selectivity indexes of 12.7 and 35.2 against Vero and HepG2 cells, respectively. Moreover, it showed specifc activity against the amastigote stage (IC50=3.31 μM). Conclusions: Results reported here suggest that natural products are an interesting source of new compounds for the development of drugs against Chagas disease. Keywords: Chagas disease, Trypanosoma cruzi, Alkaloids, Amaryllidaceae, Hippeastrine, Phenotypic assays, Cytotoxicity
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec708605
dc.identifier.issn1756-3305
dc.identifier.urihttps://hdl.handle.net/2445/177945
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13071-020-04171-6
dc.relation.ispartofParasites & Vectors, 2020, vol. 13, num. 299, p. 1-10
dc.relation.urihttps://doi.org/10.1186/s13071-020-04171-6
dc.rightscc-by (c) Martínez-Peinado, Nieves et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Biologia, Sanitat i Medi Ambient)
dc.subject.classificationMalaltia de Chagas
dc.subject.classificationMarcadors bioquímics
dc.subject.classificationAlcaloides
dc.subject.otherChagas' disease
dc.subject.otherBiochemical markers
dc.subject.otherAlkaloids
dc.titleAmaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
708605.pdf
Mida:
1.63 MB
Format:
Adobe Portable Document Format